On Friday, marijuana enthusiasts celebrate 4-20. And this year, especially, they’ve got plenty to celebrate.

We are not only on the eve of legalization, but those who market, sell and advocate for cannabis say they are tapping into a whole new market of users, too: marijuana for moms.

Former food writer Devon Scoble, who enhances her cooking with cannabis-infused oils, says it’s all part of a living a healthier lifestyle.

“I really like to use coconut oil infusions,” she says. “I find they’re very versatile. You can use them in a variety of recipes and … you can also put them on your skin.”

Others, like Hightea podcast co-host Michelle Bilodeau, say they use the product to help treat a variety of issues like depression, anxiety and aches and pains.

An Ottawa-based cannabis company has decided to take over a major California producer.

CannaRoyalty announced that it's buying FloraCal Farms in a cash and share swap.

FloraCal has a 15,000-square-foot facility in Sonoma County that produces plants in small batches. It claims that it generates an average selling price of more than US$17 per gram.

According to a joint news release, FloraCal is a sustainable producer relying 100 percent on renewable energy to produce seven cannabis flowers, rosin, and packaged pre-rolls.

The company has declared that it can achieve 28 percent to 32 percent THC content in its plants.

It generated US$6.4 million in revenue in the last fiscal year.

While alcohol is one of America’s favorite inebriating substances, it also puts users at a greater risk for dementia, according to a new study from the Centre for Addiction and Mental Health.

In the report, researchers said that alcohol was one of the most preventable risk factors in the development of nearly every type of dementia, including early onset. The consensus is that tens of thousands of people every year could be saved from this deadly disease if they could just find a way to curb their booze consumption.

With months left before Canada becomes the first country in the G7 to fully legalise marijuana, members of the country’s Liberal party, led federally by Justin Trudeau, are calling on their government to go one step further and decriminalise the possession and consumption of all illicit drugs.

How does medical marijuana help glaucoma patients? The answer is multi-layered and complex.

One of the many uses of medical marijuana is its use as a treatment for glaucoma.

This optic nerve condition can lead to loss of vision or blindness without medical assistance. Marijuana has long been hailed for its ability to reduce eye pressure, which causes glaucoma. Here we explore the question: How does medical marijuana help glaucoma patients?

What Is Glaucoma?

It’s a question that isn’t brought up often but still warrants investigation. Does cannabis affect your immune system?

Scientific research is proving more and more medical uses for cannabis. Experts cite medical marijuana as an effective treatment to use in conjunction with other medications, often to decrease their side effects.

Aurora Cannabis Inc., CanniMed Therapeutics Inc. and CTT Pharmaceutical Holdings, Inc., announced today that further to the CanniMed/CTT news release of February 17, 2017, the companies have entered into a three-way agreement that provides Aurora, through its ownership of CanniMed, with joint exclusivity on the distribution in Canada of CTT's novel, patented drug delivery technologies.

This collaboration includes the licensing by CTT to CanniMed and Aurora of six patents related to cannabinoid delivery for pain management that will enable CanniMed and Aurora to exclusively develop and commercialize this unique, sub-lingual (beneath the tongue) wafer, drug delivery system in Canada.

Israel’s Together has agreed to sell 5 tonnes of cannabis oil to an unnamed Canadian company that will potentially bring revenue of hundreds of millions of shekels.

The Canadian company will buy from Together subsidiary Globus Pharma 50 tonnes of dried inflorescences of cannabis each year, which is equivalent to five tonnes of medical cannabis oil.

The two companies will also collaborate in the field of research and development and promoting technologies in the medical cannabis sector. They have estimated sales will amount to $3.17 to $4.7 per gram of inflorescence.

Danielle Jackson, a cannatherapy consultant and edutainer also known as Miz D, says the legalization of cannabis will provide opportunities for women to show leadership through compassion. Jackson said there are therapeutic uses for cannabis for baby boomers and seniors. 

The budding cannabis industry presents opportunities for women and people looking to use their experience with cannabis when it becomes legalized in Canada later this year.

That’s according to those in the industry at the CannabisCon job fair held at the Shaw Conference Centre in Edmonton on Saturday.

Strainprint, the leader in cannabis data & analytics, is pleased to announce that Dr. Caroline MacCallum, Dr. Danial Schecter and Dr. Dean Elterman have joined its Board of Medical Advisors. Strainprint works closely with its medical advisors to support patients, enhance research and to advance the scientific understanding of cannabinoid therapy.

With over 400,000 medical records and almost 7 million data points, and growing, Strainprint is the most trusted source for strain efficacy and patient use data. Dr. MacCallum and Dr. Schecter will jointly lead Strainprint's Medical Advisory Board as Co-chairs and Dr. Elterman will focus on specific cannabinoid studies through the University Health Network.